You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A brief iPad based screening measure for HIV associated neurocognitive disorders
SBC: Digital Artefacts LLC Topic: 105Despite significance advances in anti retroviral treatments HIV associated neurocognitive disorder HAND remains prevalent and can affect a broad range of everyday activities An effective brief cognitive screen that could be implemented in busy HIV clinics where clinicians have limited time to provide care for patients with complex medical psychiatric and cognitive conditions has the poten ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Accelerating biomedical image processing using massively parallel processors
SBC: Accelereyes LLC Topic: NLMDESCRIPTION provided by applicant During the last decade the quantity of bioimaging data has grown tremendously Current estimates indicate that the average hospital in the USA houses some TB of data of which approximately is composed of unstructured image data from CT MRI and X ray machines This huge quantity of data is expected to grow at a rate of annually meaning hospita ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Advancing a Glioma Immunotherapy
SBC: IN CYTU, INC. Topic: 102DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment of glial cell based cancers Successful completion of this project will confirm therapeutic effect and pre clinical safety of the vaccine in preparation for first in human studies Upon demonstration of ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
An Automated Patient Chart Error Detection System for Radiation Therapy
SBC: Infondrian LLC Topic: 101Project Summary Abstract Every year approximately severe mistreatments happen in radiation therapy Radiation therapy lawsuits rank in the top third of all medical specialties with an average of $ per claim settled or litigated The current method for detecting treatment errors is by a weekly patient chart check where each treatment record is manually reviewed on a weekly basis Thi ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A New PET Labeled Maltodextrin for Diagnosis of Bacterial Infections
SBC: Microbial Medical, Inc. Topic: NIBIBDESCRIPTION provided by applicant We present a new family of contrast agents based on targeting the maltodextrin transporter termed maltodextrin based imaging probes MDPs which are designed to image infections associated with implanted medical devices by fluorescent imaging The chemical structure of an MDP is composed of maltodextrins conjugated to the positron emitting radioelement fluori ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A New Prostate Cancer Treatment to Improve Outcomes and Reduce Side-effects
SBC: PXALPHA, L.L.C. Topic: 102PROJECT SUMMARY ABSTRACT Among men prostate cancer is the most common non skin cancer and second leading cause of cancer death with over new diagnoses expected in Approximately of men will be diagnosed with prostate cancer in their lifetime Current treatment options for prostate cancer however have sub optimal incidences of side effects that have a significant impact on pa ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
SBC: BEHAVIORAL DIAGNOSTICS, INC. Topic: NCISmoking is the most common preventable cause of morbidity and mortality in the United States Each year smoking causes the premature death of over Americans and $ billion of economic damage Effective treatment is possible but barriers to its implementation limits the success rate of smoking cessation in the general population to about Notably reward based incentive smoking cessat ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A Saliva DNA based Epigenetic Test for Adolescent Smoking
SBC: BEHAVIORAL DIAGNOSTICS, INC. Topic: 44DESCRIPTION provided by applicant Smoking is the most common preventable cause of morbidity and mortality in the United States For of adult smokers this addiction began in adolescence Effective interventions to block the escalation of this initial smoking in adolescents exist However the implementation and effectiveness of these interventions are hindered by the inability of current bi ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Cryopreserved Adherent Neural Cell Assay Plates
SBC: ARUNA BIO, INC. Topic: 113DESCRIPTION provided by applicant Neural progenitor migration is an important process for the proper development and maintenance of the nervous system Derived from proliferative zones within the brain neural progenitors migrate to specific destinations guided by various extracellular cues Exposure to neurotoxicants during development can interfere with neural progenitor migration and lead to ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Non adjuvanted VLP Vaccine against Stealth H N Influenza
SBC: EPIVAX, INC. Topic: NIAIDDESCRIPTION provided by applicant The avian origin H N influenza virus that emerged in humans in China in presents a unique challenge to vaccine development because it is poorly immunogenic Neutralizing antibodies are not detected in acute phase infection Anti H antibody responses are significantly delayed and exhibit low avidity in comparison with antibodies generated following seas ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health